(71), IHCH9033, a new selective class I HDACi, can selectively inhibit DNA repair in FLT3-ITD AML cells, leading to DNA damage accumulation and overcoming resistance to FLT3 inhibitors. Here, FLT3 is linked to acute myeloid leukemia.